GGrantIndex
Sort

53,477 grants matching addiction

TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTER

$2,465,519
University Of Southern California · P50 · FY2002 · CA

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)

$2,465,296
Lorenzo Leggio · National Institute On Drug Abuse · ZIA · FY2024 · DA

Transmembrane Signaling Mechanisms

$2,464,608
Lutz Birnbaumer · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV

$2,461,914
Manolis Kellis · Broad Institute, Inc. · U01 · FY2021 · DA

Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord Injury

$2,460,738
Georgene W Hergenroeder · University Of Texas Hlth Sci Ctr Houston · R61 · FY2019 · NS

Neuronal anatomy, connectivity, and phenotypic innervation of the knee joint

$2,460,714
Brendan Hl Lee · Baylor College Of Medicine · UC2 · FY2025 · AR

Ohio Valley Node-Network (OVNN) of the NIDA Clinical Trials Network

$2,457,513
T John Winhusen · University Of Cincinnati · UG1 · FY2019 · DA

B Lymphocyte-Mediated Autoimmunity in Pain After Trauma

$2,454,998
David J Clark · Palo Alto Veterans Instit For Research · R01 · FY2020 · NS

Alcohol Pharmacokinetics and Pharmacodynamics in Humans

$2,454,429
Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA

TREATMENT OF ADDICTIONS--BIOLOGICAL CORRELATES

$2,451,962
Rockefeller University · P50 · FY2000 · DA

Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer

$2,450,827
Adam Joel Bass · Dana-Farber Cancer Inst · P50 · FY2019 · CA

Center for Research on Improving the Treatment of Drug Abuse

$2,448,719
Charles P O'Brien · University Of Pennsylvania · P60 · FY2010 · DA

NIDA Clinical Trials Network: New York Node

$2,448,086
John P Rotrosen · New York University School Of Medicine · UG1 · FY2020 · DA

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV

$2,447,914
Manolis Kellis · Broad Institute, Inc. · U01 · FY2022 · DA

Synaptic mechanisms underlying reward seeking and compulsive drug use

$2,446,560
Veronica A Alvarez · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA

Targeted Therapies for Glioma

$2,442,975
Tracy T Batchelor · Brigham And Women'S Hospital · P50 · FY2025 · CA

Center for Systems Neurogenetics of Addiction

$2,441,995
Elissa J Chesler · Jackson Laboratory · P50 · FY2022 · DA

Development of a Potent and Highly Selective NaV1.7 Inhibitor for the Treatment of Acute Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders

$2,440,102
John Cureton Hunter · Siteone Therapeutics, Inc. · UG3 · FY2020 · DA

Harnessing cortical neuromodulation to disrupt pain perception

$2,436,375
Gregory Corder · University Of Pennsylvania · DP2 · FY2020 · GM

HEAL: Induced Pluripotent Stem Cell (iPSC)-Derived Cell Types for Pain, Addiction and Overdose

$2,436,123
Ilyas Singec · National Center For Advancing Translational Sciences · ZIA · FY2020 · TR

Single Cell Transcriptomic and Epigenomic Dissection of Opioid and Cocaine Responses in HIV

$2,433,874
Manolis Kellis · Broad Institute, Inc. · U01 · FY2023 · DA

DSC MANAGEMENT AND SUPPORT FOR HELPING TO END ADDICTION LONG-TERM INITIATIVE (HEAL). 9/1/2021-8/31/2022. N01DA-19-2250. TASK ORDER 75N95021F00005 (TO2

$2,432,878
Paul Vanveldhuisen · The Emmes Company, Llc · N01 · FY2021 · DA

Biobehavioral Imaging and Molecular Neuropsychopharmacology of Substance Abuse Mechanisms

$2,428,804
Michael Michaelides · National Institute On Drug Abuse · ZIA · FY2024 · DA

COBRE Center on Opioids and Overdose

$2,428,175
Josiah D Rich · Rhode Island Hospital · P20 · FY2019 · GM

Integrated Care for Chronic Pain and Opioid Use Disorder: The IMPOWR Research Center at Montefiore/Einstein (IMPOWR-ME)

$2,428,171
Joanna L. Starrels · Albert Einstein College Of Medicine · RM1 · FY2023 · DA